Christian Regenbrecht

Dr. Christian Regenbrecht is co-founder and CEO of CELLphenomics.Prior to founding CELLphenomics, Christian was principal investigator at the Institute of Pathology, Charité – Universitätsmedizin Berlin and was responsible for the establishment of complex cell culture models in several publicly funded projects, including IMI’s Oncotrack and BMBF’s TREAT20. In this role, Christian acquired external funding from […]

Quirin Graf Adelmann

Quirin Graf Adelmann was born near Munich and grew up bilingually in France and Germany. After studying law at Humboldt University in Berlin, he worked as an employed managing director in the automotive and real estate sectors before becoming an independent entrepreneur in 2010.Quirin is active in the fields of culture, health, FinTech, GovTech, BioTech, […]

Christoph Reinhard

Dr. Christoph Reinhard has spend his whole career in oncology drug development in biotechnology and pharma companies with a special focus on target identification and translational research. Special emphasis lies on technologies to identify and utilize biomarkers for drug efficacy and tumor prognosis. Christoph strived to complement the company specific research with engagement in large […]

Lena Wedeken

Dr. Lena Wedeken studied human biology at the Philipps-University Marburg, Germany and obtained her PhD in molecular biology/biochemistry from the Westfälische Wilhelms-University Münster, Germany in 2011. During her postdoctoral fellowship in stem cell biology at the Beckman Research Institute of City of Hope in Duarte, CA, USA, she became an expert in the derivation and […]

Manuela Regenbrecht

Manuela Regenbrecht is the director of medical affairs at CELLphenomics. She is a medical specialist in internal medicine, hematology and oncology. Born in Berlin, she studied medicine at the Charité Universitätsmedizin Berlin as a scholarship holder from the German Academic Scholarship Foundation. She spend part of the practical year in Nepal.  She completed her subsequent residency […]